Search
Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human disease with a focus on cancer.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.
Get to know Ana Silveira, a computational biology postdoctoral fellow in the Sloan Kettering Institute.
Learn about how MSK’s new Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC.
Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.
Hear from cervical cancer survivor Susan Shaw about how she joined the Empire Dragon Boat Team three years ago and is in the best shape of her life.
Our recent prospective study data provides support for the incorporation of plasma next-generation sequencing (NGS) assays into lung cancer practice guidelines.
Researchers at Memorial Sloan Kettering (MSK) report that firefighters at the World Trade Center (WTC) scene in September 2001 were nearly twice as likely as the general population to have a multiple myeloma precursor condition called monoclonal gammopathy of undetermined significance (MGUS). This new research was published online today in JAMA Oncology.